These drugs have also been used in the treatment of inflammatory bowel disease, which evidenced their mechanism of suppressing the small GTPase Rac1, yielding anti-inflammatory and immunosuppressive effects (Table 3) [104,106,107]. This evidence concerns the gene RAC1 and inflammatory bowel disease.